Arkolith/Insider Trading/ADCT/Form 4

Redmile Group, LLC

10% OwnerADC Therapeutics SA (ADCT) · full profile →Form 4 · filed May 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 8, 2024Buy(P)8.2M$4.81$39.3M8.2M
May 8, 2024Buy(P)6.1M$4.81$29.4M6.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-059881) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML